case western reserve university



Researchers will unveil latest in medical technology at Research ShowCASE

From basic science to new technology, the breadth of cutting-edge medical research being performed at Case Western Reserve University and its partner institutions will be one of the highlights of the third annual Research ShowCASE Wednesday, April 6 and Thursday, April 7 at the university’s Veale Convocation Center.

The multi-disciplinary field of cell therapy research has recently been in the news headlines, yet Case and its partners have been at the forefront of adult stem-cell research for over 20 years. Renowned researchers Stanton Gerson, director of the Cleveland Center for Stem Cell and Regenerative Medicine, the Case Comprehensive Cancer Center, and the Ireland Cancer Center at University Hospitals; Mary Laughlin, associate professor of hematology and oncology at the Case School of Medicine; Omer Koc, associate professor of oncology at the School of Medicine; and Marc Penn, director of experimental animal laboratory and associate director of cardiovascular medicine fellowship at the Cleveland Clinic Foundation, will present their ground-breaking studies in cellular therapies from 2-6 p.m. on April 6. The symposium will focus on the partnership between the Federal Drug Administration (FDA) and scientists, and will culminate with a discussion about the translation of basic stem-cell biology into the treatment of disease.

In addition, from 11 a.m. to noon on April 7, Henry Boom, professor of pathology and director of the Tuberculosis Research Unit at Case and University Hospitals, and Michael Lederman, the Scott R. Inkley Professor of Medicine at the Case School of Medicine and director of the Center for AIDS Research at Case and University Hospitals, will share their extensive experience in TB and HIV research, including discussion of how the body recognizes and fights these infections, what clinical and epidemiologic field research entails and the ethical issues involved in studying deadly, infectious diseases. The researchers also will discuss the complicated societal issues associated with these diseases, including stigmatization, poverty and sexuality.

And with a rapidly aging population, the discussion surrounding Alzheimer’s and other neural degenerative diseases is urgent. Researchers Karl Herrup, professor of pharmacology at the School of Medicine and director of the Memory and Aging Center of University Hospitals, and George Perry, professor of pathology at the Case School of Medicine, will discuss the brain’s responses to these diseases, whether there is a timeline for a cure, and research that may lead to strategies for treatment and prevention. The panel takes place from 8:30 to 9:30 a.m. on April 7.

This year’s keynote speaker is Alvin Toffler, author of Future Shock and The Third Wave, who will participate in the keynote address at 3 p.m. on April 7 in Strosacker Auditorium. Toffler’s works predicted the digital, communications and corporate revolutions. He has written about and consulted on subjects such as technology and its impact on various societies.

Research ShowCASE is free and open to the public, but registration is recommended. To register and view a complete schedule of events as well as a listing of presenters, go to


About Case Western Reserve University

Case is among the nation's leading research institutions. Founded in 1826 and shaped by the unique merger of the Case Institute of Technology and Western Reserve University, Case is distinguished by its strengths in education, research, service, and experiential learning. Located in Cleveland, Case offers nationally recognized programs in the Arts and Sciences, Dental Medicine, Engineering, Law, Management, Medicine, Nursing, and Social Work.